Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
- Conditions
- SchizophreniaPsychoses
- Interventions
- Other: maintained antipsychotic treatment vs. stepwise drug discontinuation
- Registration Number
- NCT00159120
- Lead Sponsor
- Heinrich-Heine University, Duesseldorf
- Brief Summary
After one year neuroleptic maintenance treatment in patients with first episode schizophrenia, neuroleptic treatment will be continued vs. stepwise discontinued (randomized design) over a period of 1 year. Under both conditions prodrome based early intervention take place.
- Detailed Description
After one year neuroleptic maintenance treatment in patients with first episode schizophrenia, neuroleptic treatment will be continued vs. stepwise discontinued (randomized design) over a period of 1 year. Under both conditions pharmacologic early intervention strategies in case of early sign of relapse will be applied.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 71
- Patients after 1 year of maintenance treatment after their first-episode in schizophrenia (according ICD-10 F20)
- Age between 18 and 55
- Informed consent
- One year neuroleptic maintenance treatment
- Reaching stable course
- Residence outside of the catchment area
- Legal reasons
- Insufficient knowledge of the german language
- Substance abuse or addiction
- Pregnancy
- Serious physical illness
- Organic brain disease
- Contraindication to neuroleptic treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 maintained antipsychotic treatment vs. stepwise drug discontinuation further maintenance antipsychotic treatment and prodrome-based early intervention 2 maintained antipsychotic treatment vs. stepwise drug discontinuation stepwise drug discontinuation (after 1 year maintenance antipsychotic treatment) and prodrome-based early intervention
- Primary Outcome Measures
Name Time Method relapse rate 1 year
- Secondary Outcome Measures
Name Time Method psychopathology 1 year social and cognitive functioning 1 year side-effects 1 year drop-out 1 year quality of life 1 year
Trial Locations
- Locations (1)
German Research Network on Schizophrenia, Department of Psychiatry and Psychotherapy at the Heinrich-Heine-University Düsseldorf
🇩🇪Düsseldorf, North Rhine-Westphalia, Germany